“…To defend this from colonization by microbial competitors, a broad spectrum of antimicrobials is produced. These include antifungals: biocornutin ( Böszörményi et al, 2009 ), cabanillasin ( Houard et al, 2013 ), EP-19, GP-20 ( Xiao et al, 2012 ), and xenocoumacin ( Yang et al, 2011 ); antibacterials: darobactin ( Imai et al, 2019 ), xenematide ( Lang et al, 2008 ), photoditritide ( Zhao et al, 2019 ), xenobactin ( Grundmann et al, 2013 ), odilorhabdins ( Pantel et al, 2018 ), xenorhabdin ( McInerney et al, 1991 ), and PAX peptides ( Gualtieri et al, 2009 ); antiprotozoals: phototemtide ( Zhao et al, 2020 ), szentiamide ( Ohlendorf et al, 2011 ), chaiyaphumins ( Grundmann et al, 2014 ), rhabdopeptide/xenortide-like peptides (RXP) ( Zhao L. et al, 2018 ), xenortide ( Reimer et al, 2014 ), xenoamicin ( Zhou et al, 2013 ), and ambactin ( Schimming et al, 2014 ); and cytotoxic agents: fabclavines ( Wenski et al, 2020 ) and phenylethylamine (PEA) derivatives ( Proschak et al, 2011 ).…”